Tiziana Life Sciences announces proposed US public offering
Tiziana Life Sciences
58.50p
16:35 20/10/21
8.33%
4.50p
Biotechnology company Tiziana Life Sciences announced the commencement of an underwritten public offering in the United States on Tuesday, of American Depositary Shares (ADSs) representing ordinary shares, on the Nasdaq Global Market.
Pharmaceuticals & Biotechnology
21,835.30
14:00 23/04/24
0.21%
45.10
The AIM-traded firm said there could be no assurance as to whether or when the offering could be completed, or as to the actual size or terms of the offering, with the price for the offering not yet determined.
It said all ADSs to be sold in the offering would be offered by the company, with the number of ordinary shares represented by ADSs comprised in the offering to be within existing shareholder authorities.